Litigation Details for Illumina, Inc. v. BGI Genomics Co., Ltd (N.D. Cal. 2019)
✉ Email this page to a colleague
Illumina, Inc. v. BGI Genomics Co., Ltd (N.D. Cal. 2019)
Docket | ⤷ Try a Trial | Date Filed | 2019-06-27 |
Court | District Court, N.D. California | Date Terminated | 2022-05-10 |
Cause | 35:271 Patent Infringement | Assigned To | William Horsley Orrick III |
Jury Demand | Both | Referred To | Thomas S. Hixson |
Parties | ILLUMINA, INC. | ||
Patents | 8,227,230; 8,324,283; 9,020,056 | ||
Attorneys | Krista M. Carter | ||
Firms | Arnold & Porter LLP | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Illumina, Inc. v. BGI Genomics Co., Ltd
Biologic Drugs cited in Illumina, Inc. v. BGI Genomics Co., Ltd
Details for Illumina, Inc. v. BGI Genomics Co., Ltd (N.D. Cal. 2019)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2020-09-02 | 239 | Antimicrobial Agents and Chemotherapy 1975; 8:227-230. 2. Smith DI, Blattner FR, Davies JE. The isolation…Defendants’ products infringe certain claims of U.S. Patent Nos. 13 7,771,973, 7,566,537, 7,541,444, 9,410,200…They were also successfully sued by Illumina for patent infringement, in which Illumina 19 received an… 149. Illumina’s claims that, if their patents are not upheld and in absence of an injunction,… 2019 10 May 2022 3:19-cv-03770 830 Patent Both District Court, N.D. California | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |